SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage in acute ...

History of previous heart disease, AMI, or myocardial revascularization were protective factors ... to the fact that women appear to be more vulnerable to prolonged untreated ischemia. 10 The longest ...

duke-nus.edu.sg Despite prompt reperfusion by primary percutaneous coronary intervention (PPCI), the mortality and morbidity of patients presenting with an acute ST-segment elevation myocardial ...

Introduction Lung transplantation is an established treatment for patients with end-stage lung disease. However, ischaemia reperfusion injury remains a barrier to achieving better survival outcomes.

Jiangsu Key Laboratory for Biomaterials and Devices, School of Biomedical Sciences and Medical Engineering, Southeast University, Nanjing 210096, P. R. China Department of Cardiology, Nanjing Drum ...

Current understanding of microvascular changes in chronic limb-threatening ischemia remains limited, partly because the tissue microvasculature is difficult to study in human patients.

The classical description of patients with acute limb ischemia is represented by the "six Ps": pain, pallor, paralysis, pulse deficit, paresthesia, and poikilothermia. Pain may be either constant ...

Myocardial ischemia-reperfusion injury (MIRI) is a significant factor in the development of cardiac dysfunction following a myocardial infarction. Ferroptosis, a type of regulated cell death driven by ...

The ischemic heart may be further damaged after reperfusion therapy with percutaneous coronary intervention (PCI) and other methods, namely, myocardial ischemia–reperfusion injury (MIRI), which ...